Inflammatory Status
4
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Nacetylcysteine Supplementation
Research Leaders
7 sponsors active, led by Democritus University of Thrace
Related Conditions
Often studied with 11 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Impact of Chromium Supplementation on Glucido-lipidic Metabolism, Oxidative Stress and Inflammatory State in Patients with Gestational Diabetes
FOUND - Ancillary Study to Smile Protocol NCT03654105
HFR Cartridge and Inflammation
NAC Supplementation and Skeletal Muscle Performance
Research Network
Common Treatments
- Nacetylcysteine Supplementation1
- Oral Chromium Supplementation During Gestational Diabetes Mellitus Through The Administration Of Chromium Picolinate Tablets 200 Μgd1
- Hfr Dialysis1
- Dietary Supplement Oral Chromium Supplementation During Gestational Diabetes Mellitus Through The Administration Of Chromium Picolinate Tablets 400 Μgd1
Active Sponsors
- Democritus University of Thrace1
- University of Parma1
- Federico II University1
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
- University of Kasdi Merbah1
Top Investigators
Democritus University of Thrace, Greece
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Related Conditions
- Covid 191
- Insulin Resistance1
- Lipid Metabolism Disorders1
- Oxidative Stress1
- Gestational Diabetes Mellitus Gdm1